The Latest in Obesity

Docs weigh in on insurance coverage for obesity medications

October 18, 2023

Scientists find the ‘on’ switch for energy-burning brown fat

October 18, 2023

Metformin, weight management to stop type 2 diabetes in kids

October 17, 2023

New ‘twincretin’ pemvidutide: Another option for obesity

October 17, 2023

Obesity

Roflumilast side effect benefits patients with psoriasis and overweight/obesity

October 16, 2023

Obesity linked to multiple ills in MS study

October 13, 2023

Are they ‘antiobesity medications’ or ‘weight-loss drugs’?

October 12, 2023

Obesity

The new word in liver disease: The story behind NAFLD’s rebranding as MASLD

October 5, 2023

Weight loss with semaglutide maintained for up to 3 years

October 4, 2023

When to prescribe semaglutide?

October 2, 2023

FDA gives semaglutide two drug safety–related label changes

September 28, 2023

The ‘triple-G’ agonist for obesity management: Five things to know

September 25, 2023

Obesity

Tirzepatide superior to semaglutide for A1c control, weight loss

September 25, 2023

Waist-hip ratio a stronger mortality predictor than BMI

September 21, 2023

Obesity

‘New dawn’ for aldosterone as drug target in hypertension?

September 12, 2023